Background: Value-based pricing (VBP), whereby prices are set according to the perceived benefits offered to the … much discussed topic in pharmaceutical reimbursement. It is usually combined with coverage with evidence development (CED …), a tool in which manufacturers are granted temporary reimbursement but are required to collect and submit additional …

its current drug reimbursement process because of budgetary constraints. One method of achieving this is to implement a … importance in the decision making around drug reimbursement. Second, a set of priority treatments to be assessed was determined …. Once the treatments eligible for reimbursement were determined, scores were assigned to these treatments according to their …

reimbursement and pricing of approved drugs, the so-called fourth and fifth hurdles. Methods: We reviewed 38 National Institute for … sharing and conditions of reimbursement on three-tier formularies used by seven leading US third-party payers serving Medicare … approved. Thirdly, we considered whether and when each drug was recommended for reimbursement and use by NICE, and whether …

Sweden has experienced a national value-based pricing (VBP) system for innovative outpatient drugs operated by the … character of a monopoly system, leading to reimbursement decisions where usage of new medicines is limited to subgroups and not … system. The aim of this article is to suggest a modification to the current reimbursement system in Sweden where payment for …